‘States Should Check ICMR Portal, Track Those Testing +Ve Via Home Kits’

PUNE : All states should check the Indian Council of Medical Research (ICMR) portal to tra-ck and treat people testing positive via home Covid test kits, officials from the research body said. They were responding to concerns that states were missing out on cases testing positive via home test kits.

MyLab’s Coviself—a home-based rapid antigen kit—hit pharmacies last week. The rapid test kit requires a nasal swab sample to provide test results within 15 minutes. State health officials said the data from the rapid kits is key as the five-level unlock process relies on testing information and positivity rates.

ICMR officials said the home-based test kits are linked to the ICMR portal via software and states can access patient data—including home address—from the website. “All states have user credentials to access the ICMR test portal. They have to access the portal to update their data. The data can be found under home-based test kits. Officials can check for data from their respective states and local authorities can then contact the person who has tested positive,” a senior ICMR official said.

After Coviself, two more home testing kits—PanBio and Covifind—are expected to hit the market soon. “All these home test kits will be linked to the ICMR portal, which will have data of positive patients and number of tests,” the ICMR official added.

State health officials have raised concerns about tracking those testing positive via home kits bought over the counter. “All purchases of home kits should be strictly monitored. There should also be a mechanism that ensures local authorities, and not a centralised portal, are first alerted about a positive case,” a state official said.

Representatives from Mylab, which makes Coviself, said local authorities in Pune have been able to reach out to people testing positive. “The system is in place and will be fortified further,” a Mylab official said.

According to company officials about 30 lakh Coviself kits have been distributed to pharmacies and drug stores nationwide. The volume will be scaled up, they said. “We are ready with a capacity of 1 crore per week. We will react to market demand,” said a Mylab official. The firm’s MD, Hasmukh Rawal, said they plan to improve reach in rural areas.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India